Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Pliant Therapeutics (PLRX)

Annual Return

Over the past 3 years, PLRX has had an average annual return of -62.44%, underperforming the benchmark SPY, which returned +22.45% annual.

Over the past 5 years, PLRX has had an average annual return of -47.98%, underperforming the benchmark SPY, which returned +13.88% annual.

Since Jun 3, 2020, PLRX has had an average annual return of -38.24%, underperforming the benchmark SPY, which returned +17.47% annual.

2026202520242023202220212020
-3.32%-90.73%-27.28%-6.31%+43.18%-40.58%+6.67%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026-0.87%+7.39%-2.95%-3.21%+3.32%-6.42%-3.32%
2025-18.37%-68.00%-60.74%+17.67%-15.01%-14.04%+25.69%+12.41%-9.74%+13.53%-4.18%-24.21%-90.73%
2024-1.05%-11.43%-6.12%-20.67%+2.63%-11.38%+33.11%-7.13%-15.64%+25.52%-1.92%-4.57%-27.28%
2023+81.28%-9.08%-16.51%+6.21%-23.43%-16.23%-1.54%-5.38%+2.73%-15.40%-5.31%+30.38%-6.31%
2022-13.11%-23.53%-21.85%-16.41%-3.93%+42.30%+116.83%+11%+8.35%+19.05%-26.10%+5.17%+43.18%
2021+8.32%+34.46%+18.86%-14.82%-10.27%-3.13%-30.63%-9.71%-7.45%-5.63%-10.99%-4.79%-40.58%
2020+52.39%-28.25%+7.99%-9.94%-4.55%+27.29%-17.44%+6.67%

Drawdown analysis of Pliant Therapeutics (PLRX)

The maximum drawdown for the PLRX was -97.29%, occurring on Feb 5, 2026. This drawdown has not yet recovered.

The current PLRX drawdown is -97.07%.

Since Jun 3, 2020 PLRX has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 3 times
  • 10% or more: 3 times
DepthStartTo BottomBottomTo RecoverEndTotal
-97.29%Mar 25, 20211222Feb 5, 2026OngoingOngoingOngoing
-43.59%Jun 29, 202066Oct 1, 202099Feb 24, 2021165
-21.35%Feb 24, 20217Mar 5, 202114Mar 25, 202121
-5.82%Jun 4, 20203Jun 9, 20204Jun 15, 20207
-2.53%Jun 15, 20201Jun 16, 20201Jun 17, 20202
-0.03%Jun 19, 20201Jun 22, 20201Jun 23, 20202